Found 8 results
Author [ Title(Desc)] Type Year
Filters: First Letter Of Title is S and Author is Barin, B  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
F. M. Kibengo, Ruzagira, E., Katende, D., Bwanika, A. N., Bahemuka, U., Kamali, A., Haberer, J. E., Bangsberg, D. R., Barin, B., Rooney, J. F., Mark, D., Chetty, P., Fast, P., and Priddy, F. H., Safety, Adherence and Acceptability of Intermittent Tenofovir/Emtricitabine as HIV Pre-exposure Prophylaxis (PrEP) among HIV-Uninfected Ugandan Volunteers Living in HIV-Serodiscordant Relationships: A Randomized, Clinical Trial, PLoS One, vol. 8, p. e74314, 2013.
G. Mutua, Sanders, E., Mugo, P., Anzala, O., Haberer, J. E., Bangsberg, D., Barin, B., Rooney, J. F., Mark, D., Chetty, P., Fast, P., and Priddy, F. H., Safety and Adherence to Intermittent Pre-Exposure Prophylaxis (PrEP) for HIV-1 in African Men Who Have Sex with Men and Female Sex Workers, PLoS One, vol. 7, p. e33103, 2012.
J. W, FN, N., O, A., G, O. Manyonyi, J, B., A, N., F, B., K, B., H, O., S, W., L, M., W, W., J, O., M, O., J, I., J, N. - A., C, K., ,, Smith, C., Barin, B., Dally, L., ,, and Kaleebu, P., Safety and Immunogenicity of Recombinant Low-Dosage HIV-1 A Vaccine Candidates Vectored by Plasmid pTHr DNA or Modified Vaccinia Virus Ankara (MVA) in Humans in East Africa, Vaccine, vol. 26, pp. 2788-2795, 2008.
G. Mutua, Hanke, T., Fast, P., Hannaman, D., Chinyenze, K., Oino, G., Sajabi, R., Verlinde, C., Barin, B., Reilly, M., and Jaoko, W., Safety and Tolerability of pSG2.HIVconsv DNA MVA.HIVconsv and Ad35-GRIN Prime-Boost Combinations Administered to Healthy HIV-Uninfected Kenyan Adults, in HIV R4P 2016, Chicago, IL, 2016.
B. S. Peters, Jaoko, W., Vardas, E., Panayotakopoulos, G., Fast, P., Schmidt, C., Gilmour, J., Bogoshi, M., G Manyonyi, O., Dally, L., Klavinskis, L., Farah, B., Tarragona, T., Bart, P. - A., Robinson, A., Pieterse, C., Stevens, W., Thomas, R., Barin, B., and Bwayo, J. [..], Studies of a Prophylactic HIV-1 Vaccine Candidate Based on Modified Vaccinia Virus Ankara (MVA) with and without DNA Priming: Effects of Dosage and Route on Safety and Immunogenicity, Vaccine, vol. 25, pp. 2120-2127, 2007.
J. Harbell, Fung, J., Nissen, N., Olthoff, K., Florman, S., Hanto, D., Light, J., Bartlett, S., Tzakis, A., Pearson, T., Barin, B., Roland, M., and Stock, P., Surgical Complications in 275 HIV-Infected Liver and/or Kidney Transplantation Recipients, Surgery, vol. 152, pp. 376-381, 2012.
M. E. Roland, Barin, B., Huprikar, S., Wong, M., Blumberg, E., Simon, D., Ragni, M., Stablein, D., and Stock, P. G., Survival in HIV-Positive Transplant Recipients Compared to Matched Registry Controls., in Conference on Retroviruses and Opportunistic Infections (CROI), Seattle, WA, 2015.
M. E. Roland, Barin, B., Huprikar, S., Murphy, B., Hanto, D. W., Blumberg, E., Olthoff, K., Simon, D., Hardy, W. D., Beatty, G., and Stock, P. G., Survival in HIV-positive Transplant Recipients Compared with Transplant Candidates and with HIV-negative Controls, AIDS, vol. 30, no. 3, pp. 435-444, 2016.